Three neurobiologically distinct psychosis “biotypes” have been identified that appear to cross clin...

Higher levels of hostility are linked with earlier treatment discontinuation in people with schizoph...

A recent study published in JAMA Psychiatry reports that adults with schizophrenia die at 3.5 times ...

The presence of a genetic polymorphism and the speed with which a patient metabolizes risperidone ma...

Microglial activity—indicative of an immune response to neuroinflammation—appears to be elevated in ...

People with schizophrenia may be at a higher risk for dementia with an earlier age at onset than tho...

The Food and Drug Administration (FDA) last week approved Vraylar (cariprazine), a dopamine D2/D3 re...

Yesterday, the Food and Drug Administration announced that it is making changes to the requirements ...

Although it is well established that patients with schizophrenia have deficits in cortical gray matt...